Company Filing History:
1 out of 155 
1 out of 23 
Years Active: 2013
Title: Tanja Heimberger - Innovator in Parvovirus Cancer Therapy
Introduction
Tanja Heimberger is an inventor based in Wuerzburg, Germany. He is known for his innovative work in the field of cancer therapy, particularly focusing on the use of parvoviruses in combination with chemotherapy. His research aims to enhance the effectiveness of cancer treatments and provide new options for patients suffering from various types of tumors.
Latest Patent Applications
Tanja Heimberger has submitted a patent application titled "Parvovirus Cancer Therapy and Combination with Chemotherapy." This application describes a pharmaceutical composition that includes (a) a parvovirus and (b) a chemotherapeutic agent, preferably administered as separate entities. The parvovirus may be derived from several sources, including parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), Rat virus (RV), and vectors based on these viral species. The composition is designed to treat tumors, particularly glioma, medulloblastoma, meningioma, and pancreatic cancer. Preferred chemotherapeutic agents mentioned in the application are gemcitabine and Temozolomide.
Conclusion
Tanja Heimberger's contributions to cancer therapy through his innovative patent application highlight the potential of parvoviruses in enhancing treatment efficacy. His work represents a significant step forward in the ongoing battle against cancer.